Microbiota Intervention Strategies Limiting Selection and Transmission of Antibiotic Resistance burden in the One Health domain
Proyectos Europeos
Para más información, contactar con el equipo de getión de proyectos Internacionales en oficina.idi(ELIMINAR)@irycis.org
SO-NUTS
JU
Preventing obesity, sarcopenia, and Sarcopenic Obesity in retirement - digital personalized interventions for healthy NUTrition and physical activity for Seniors.
ST131TS
JPI
Escherichia coli ST131: a model for high-risk transmission dynamics of antimicrobial resistance.
European upconversion network.
COST
The European upconversion network - from the design of photon-upconverting nanomaterials to biomedical applications (CM1403).
Nano2Clinic
COST
Cancer Nanomedicine – from the bench to the bedside (CA17140)
REPLAY (MSCA-IF)
MSCA / ERC
Analysing the role of history, chance and selection on the evolution of plasmid-mediated antibiotic resistance (895671).
RETENTION
H2020
heaRt failurE paTient managEment and iNTerventIOns usiNg continuous patient monitoring outside hospitals and real world data (965343)
RESILIENCE
H2020
Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines (945118).
VISION
H2020
Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers (857381)
MICROCARE
FP7
A multicenter, randomized, placebo-controlled, parallel-arm clinical trial to evaluate the efficacy of DAV132 in preventing Clostridioides difficile infection in patients with newly diagnosed Acute Myeloid Leukemia or high-risk Myelodysplastic Syndrome treated with intensive chemotherapy.